Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Covington
Accenture
Boehringer Ingelheim
Chinese Patent Office
Queensland Health
McKesson
Dow
Cerilliant

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019759

« Back to Dashboard

NDA 019759 describes SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Icu Medical Inc, and Miles, and is included in eleven NDAs. It is available from three suppliers. Additional details are available on the SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER profile page.

The generic ingredient in SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and fifty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 019759
Tradename:SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Applicant:Hospira
Ingredient:sodium chloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019759
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019759 NDA Hospira, Inc. 0409-7132 0409-7132-02 24 POUCH in 1 CASE (0409-7132-02) > 1 BAG in 1 POUCH > 250 mL in 1 BAG (0409-7132-04)
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019759 NDA Hospira, Inc. 0409-7132 0409-7132-66 10 POUCH in 1 CASE (0409-7132-66) > 5 BAG in 1 POUCH > 50 mL in 1 BAG (0409-7132-68)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength450MG/100ML
Approval Date:Jun 8, 1988TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Express Scripts
Colorcon
UBS
Cerilliant
Cipla
Citi
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.